Published in N Engl J Med on February 07, 1980
Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest (1991) 2.63
Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Br J Cancer (1988) 1.18
Effects of disodium dichloromethylene diphosphonate on bone loss in paraplegic patients. J Clin Invest (1981) 1.14
(Dichloromethylene)diphosphonate-induced impairment of T-lymphocyte function. Proc Natl Acad Sci U S A (1983) 0.98
Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro. J Clin Invest (1982) 0.98
Review of health-related quality of life data in multiple myeloma patients treated with novel agents. Leukemia (2013) 0.88
Medical management of hypercalcaemia. Br J Clin Pharmacol (1992) 0.84
Gut-mediated hypercalcemia in rabbits bearing VX2 carcinoma: new mechanism for tumor-induced hypercalcemia. Proc Natl Acad Sci U S A (1982) 0.83
The influence of 1-hydroxyethane-1,1-diphosphonate and dichloromethanediphosphonate on lysine hydroxylation and cross-link formation in rat bone, cartilage and skin collagen. Biochem J (1981) 0.80
Increase in fatty acid oxidation in calvaria cells cultured with diphosphonates. Biochem J (1981) 0.77
Drug treatment of primary hyperparathyroidism: use of clodronate disodium. Br Med J (Clin Res Ed) (1983) 0.76
Oncology. Postgrad Med J (1990) 0.75
Problems in the management of myeloma. Postgrad Med J (1989) 0.75
Clodronate in hypercalcemia of malignancy. Calcif Tissue Int (1990) 0.75
Incidence of early loss of pregnancy. N Engl J Med (1988) 9.21
Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med (1966) 9.20
Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network. N Engl J Med (1999) 4.42
Crystal structure of human chorionic gonadotropin. Nature (1994) 3.06
Skeletal disease in primary hyperparathyroidism. J Bone Miner Res (1989) 3.00
Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol (2001) 2.54
The amino acid sequence of human plasma prealbumin. J Biol Chem (1974) 2.11
Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 2.11
Measurement of fibrinopeptide A in human blood. J Clin Invest (1974) 2.01
Structure of human chorionic gonadotropin at 2.6 A resolution from MAD analysis of the selenomethionyl protein. Structure (1994) 1.87
Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pract (2001) 1.81
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int (2010) 1.69
Mixing two monoclonal antibodies yields enhanced affinity for antigen. J Immunol (1982) 1.61
Lymphoproliferative disorders and motor neuron disease: an update. Neurology (1997) 1.54
Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin. N Engl J Med (1980) 1.54
Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J Clin Invest (1979) 1.54
Structural identity of Bence Jones and amyloid fibril proteins in a patient with plasma cell dyscrasia and amyloidosis. J Clin Invest (1973) 1.51
Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases. Ann N Y Acad Sci (1971) 1.48
The amino acid sequence of human chorionic gonadotropin. The alpha subunit and beta subunit. J Biol Chem (1975) 1.45
Partial amino acid sequence of human placental lactogen precursor and its mature hormone form produced by membrane-associated enzyme activity. Biochem Biophys Res Commun (1977) 1.40
Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med (1990) 1.39
Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. N Engl J Med (1974) 1.38
Studies of human chorionic gonadotropin. Recent Prog Horm Res (1971) 1.36
Measuring early pregnancy loss: laboratory and field methods. Fertil Steril (1985) 1.34
Effects of lysozyme on normal and transformed mammalian cells. Nature (1973) 1.33
Monocytic and monomyelocytic leukaemia with increased serum and urine lysozyme as a late complication in plasma cell myeloma. Br Med J (1971) 1.32
The epitope associated with the binding of the capsular polysaccharide of the group B meningococcus and of Escherichia coli K1 to a human monoclonal macroglobulin, IgMNOV. J Exp Med (1988) 1.27
Radioimmunoassay of human fibrinopeptide A. Proc Natl Acad Sci U S A (1971) 1.26
Properties of the subunits of human chorionic gonadotropin. Endocrinology (1974) 1.18
Nature of the subunits of human chorionic gonadotropin. Endocrinology (1971) 1.17
Localization of lysozyme in normal rat tissues by an immunoperoxidase method. J Histochem Cytochem (1974) 1.16
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication. Clin Pharmacol Ther (1985) 1.15
Human lysozyme (origin and distribution in health and disease). Ric Clin Lab (1979) 1.15
Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2008) 1.15
Use of monoclonal antibodies to subunits of human chorionic gonadotropin to examine the orientation of the hormone in its complex with receptor. Proc Natl Acad Sci U S A (1982) 1.14
Experimental Bence Jones cast nephropathy. Lab Invest (1976) 1.13
Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology (1987) 1.12
Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia. Am J Med (1969) 1.11
Mechanism of action of choleragen and the glycopeptide hormones: is the nicotinamide adenine dinucleotide glycohydrolase activity observed in purified hormone preparations intrinsic to the hormone? Endocrinology (1978) 1.11
Absence of neutralizing effect of antisera to the unique structural region of human chorionic gonadotropin. J Clin Endocrinol Metab (1974) 1.10
Effects of childhood leukemia and chemotherapy on puberty and reproductive function in girls. N Engl J Med (1976) 1.08
The expression, characterization, and crystallization of wild-type and selenomethionyl human chorionic gonadotropin. Endocrinology (1995) 1.08
A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group. Am J Med (1999) 1.08
Peripheral neuropathy and anti-MAG antibodies. Crit Rev Neurobiol (1988) 1.07
Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int (2012) 1.07
Plasmacytic reticulum cell sarcoma. Case report with electron microscopic studies. Am J Clin Pathol (1966) 1.06
Use of a highly sensitive and specific immunoradiometric assay for detection of human chorionic gonadotropin in urine of normal, nonpregnant, and pregnant individuals. J Clin Endocrinol Metab (1984) 1.06
Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study. Osteoporos Int (2007) 1.06
Isolation and amino acid sequence of COOH-terminal fragments from the beta subunit of human choriogonadotropin. J Biol Chem (1977) 1.06
Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2007) 1.05
Plasma cell dyscrasia and peripheral neuropathy: identification of the myelin antigens that react with human paraproteins. Proc Natl Acad Sci U S A (1981) 1.05
Beyond bone mineral density: can existing clinical risk assessment instruments identify women at increased risk of osteoporosis? J Intern Med (2004) 1.05
Human monoclonal macroglobulins with specificity for Klebsiella K polysaccharides that contain 3,4-pyruvylated-D-galactose and 4,6-pyruvylated-D-galactose. J Exp Med (1980) 1.04
THE INTRACELLULAR DISTRIBUTION OF GAMMA GLOBULIN IN A MOUSE PLASMA CELL TUMOR (X5563) AS REVEALED BY FLUORESCENCE AND ELECTRON MICROSCOPY. J Exp Med (1962) 1.04
Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes. J Clin Invest (1975) 1.04
A clinical approach to diagnosis and management of Paget's disease of bone. J Bone Miner Res (2001) 1.04
Bisphosphonates and iritis. Lancet (1993) 1.03
The development of assays for the detection of fibrin(ogen)olysis based on COOH-terminal A alpha chain epitopes. Blood (1994) 1.02
Evidence for a gonadotropin from nonpregnant subjects that has physical, immunological, and biological similarities to human chorionic gonadotropin. Proc Natl Acad Sci U S A (1976) 1.01
Notation for human immunogobulin subclasses. Bull World Health Organ (1966) 1.01
Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias. Semin Oncol (1986) 1.01
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int (2013) 1.00
Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine. Endocrinology (1988) 1.00
Monoclonal IgM kappa antibody precipitating with chondroitin sulfate C from patients with axonal polyneuropathy and epidermolysis. Neurology (1983) 0.99
Complement-fixing antiperipheral nerve myelin antibodies in patients with inflammatory polyneuritis and with polyneuropathy and paraproteinemia. Neurology (1981) 0.98
Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP). Clin Orthop Relat Res (1983) 0.98
Letter: Human chorionic gonadotropin: a proposal for the amino acid sequence. Mol Cell Biochem (1973) 0.97
An approach for identifying postmenopausal women age 50-64 years at increased short-term risk for osteoporotic fracture. Osteoporos Int (2007) 0.96
Giant cell tumor in Paget's disease of bone: familial and geographic clustering. Cancer (1979) 0.96
Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline. J Clin Invest (1979) 0.93
Two antigenic subtypes of human lambda immunoglobulin chains. J Immunol (1969) 0.93
Response of 1alpha,25-dihydroxyvitamin D3 to hypocalcemia in human subjects. N Engl J Med (1978) 0.93
Development of a radioimmunoassay for the fibrinogen-derived peptide B beta 1-42. Blood (1986) 0.93
Primary structure of lysozymes from man and goose. Nat New Biol (1971) 0.93
Crystallization of human lysozyme. Science (1967) 0.93
The rates of dissociation and reassociation of the subunits of human chorionic gonadotropin. Arch Biochem Biophys (1973) 0.92
Long-term therapy of Paget's disease of bone with EHDP. Arthritis Rheum (1980) 0.92
Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia. J Neurol Neurosurg Psychiatry (1984) 0.92
Osteoporosis care at risk in the United States. Osteoporos Int (2008) 0.91
The effects of crude and purified human gonadotropin on in vitro stimulated human lymphocyte cultures. Cell Immunol (1976) 0.91
Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay. Fertil Steril (1987) 0.91
Gait analysis of patients who have Paget disease. J Bone Joint Surg Am (1989) 0.91
Reactivity of fibrinogen and fibrinopeptide A containing fibrinogen fragments with antisera to fibrinopeptide A. Biochemistry (1976) 0.90
Primary structure of rat lysozyme. Biochemistry (1977) 0.90
Use of specific antisera to characterize biologic activity of hCG-beta subunit preparations. Endocrinology (1972) 0.90
A new reference preparation of human chorionic gonadotrophin and its subunits. Bull World Health Organ (1976) 0.90
Immunofluorescence study of patients with neuropathy and IgM M proteins. Ann Neurol (1985) 0.89
Primary structure of a deleted human lambda type immunoglobulin light chain containing carbohydrate: protein Sm lambda. Proc Natl Acad Sci U S A (1975) 0.89
Quantitative recovery, selective removal and one-step purification of human parotid and leukemic lysozymes by immunoadsorption. Eur J Biochem (1982) 0.89
Lysozyme and fibrinogen in normal and leukemic blood cells: a quantitative electron immunocytochemical study. Johns Hopkins Med J (1970) 0.89
Expression of human chorionic gonadotropin uniformly labeled with NMR isotopes in Chinese hamster ovary cells: an advance toward rapid determination of glycoprotein structures. J Biomol NMR (1996) 0.89
Development of an immunoassay for the COOH-terminal region of the gamma chains of human fibrin. Thromb Res (1982) 0.89
Specificity and idiotype of M-proteins that react with MAG in patients with neuropathy. J Immunol (1983) 0.88